Chemycal has been acquired by 3E

Learn More

ANSES opiinion on the development of a chronic TRV by the respiratory route for 1,3-butadiene


Your substances

None

This news contains references also to other Substances


On 11 April 2019, ANSES received a formal request from the Directorate General for Health (DGS) and the Directorate General for Risk Prevention (DGPR) to carry out the following expert appraisal: formal request on the selection or development of toxicity reference values (TRVs) for 1,3-butadiene.

CONTINUE READING ON www.anses.fr

                   

Related News

Loading...